鶹AV

Skip to main content
Back to Top
Apply Giving
Resources for:
Students
Students Faculty & Staff Parents & Family Alumni Community
鶹AV Logo
  • Academics

    Academics Home

    Colleges & Schools

    Programs of Study
    • Degrees & Programs
    • Program Pathways
    • Academic Calendar
    • Online Programs
    Resources
    • Advising
    • Counseling Services
    • Honors Program
    • Learning & Academic Support
    • Libraries
    • Testing & Disability Services
    • Writing Center
    Outside the Classroom
    • Army ROTC
    • Study Abroad
    • Experiential Learning
    • First Year Experience
    • Center for Undergraduate Research
    • Career Services
    • Jags Live Well
  • Admissions

    Admissions Home

    Request Information

    Apply to AU
    • First-Year Freshmen
    • Transfer Students
    • Dual Enrollment
    • Graduate Students
    • Medical College of Georgia
    • Dental College of Georgia
    Opportunities
    • Degree & Programs
    • Honors Program
    • Program Pathways
    • Military-Affiliated Students
    • New Student & Family Transitions
    • On-Campus Housing
    Financial Aid
    • Student Financial Aid
    • Net Price Calculator
    • Scholarships
    • Cost of Attendance
    • Apply for Federal Aid
  • Campus Life

    Campus Life Home

    Community
    • Army ROTC
    • Living-Learning Communities
    • Military & Veteran Services
    • Mentorship
    • New Student & Family Transitions
    • Jags 4 Jags Mentoring Program
    Campus Services
    • Dining Services
    • Roarstore
    • Housing
    • Student Health
    • Parking & Transportation
    • Jagcard
    Get Involved
    • Clubs & Organizations
    • Greek Life
    • Campus Recreation
    • Student Government
    • Jaguar Production Crew
    • Intramural Sports
  • Research

    Research Home

    Opportunities
    • Undergraduate Research
    • Graduate & Postdoctoral Research
    • Clinical Trials
    • Core Laboratories
    • Innovation Commercialization
    Initiatives
    • Cancer
    • Cardiovascular
    • Immunology
    • Neuroscience
    • Aging
    Resources
    • Centers & Institutes
    • Ethics & Compliance
    • Institutional Review Board
    • Sponsored Programs
    • Tools for Researchers
  • About AU

    About AU

    Leadership
    • President
    • Provost
    • Administration
    • Enrollment Student Affairs
    • Faculty Senate
    We are AU!
    • Our Mission
    • Working at AU
    • Traditions
    • History
    • 鶹AV, GA
    Resources
    • Portals
    • Faculty Directory
Resources For
  • Current Students
  • Faculty & Staff
  • Parents & Family
  • Alumni & Friends
Apply
Giving
Trending Search Terms
  • Registrar
  • Housing
  • Academic Calendar
  • Financial Aid
  • Parking
  • Library
  • Human Resources
  • Information Technology
Medical College of GeorgiaFaculty | Cellular Biology & Anatomy
Faculty | Cellular Biology & Anatomy
  • People
    • Message from the Chair
    • Faculty
    • Staff and Fellows
    • Administration
  • Education
    • Education 
    • CB&A Graduate Program
      • CB&A Graduate Program
      • Graduate Students
  • Research
    • Research
    • Labs
      • Electron Microscopy and Histology Core Laboratory
      • Cell Imaging Core Laboratory
  • Anatomical Donations
    • Anatomical Donations
    • Memorial Service
    • Coordinator
  • News & More
    • News
    • Retreat
  • 鶹AV
  • Colleges & Schools
  • Medical College of Georgia
  • Cellular Biology & Anatomy
  • Faculty | Cellular Biology & Anatomy
  • Zheng Dong, PhD

Zheng Dong, PhD

Zheng Dong

 

Regents' Professor,
Leon H. Charbonnier Endowed Chair,
Director of Kidney Disease Research Center

Medical College of Georgia at 鶹AV


Senior Research Career Scientist, Director of Research Development
Charlie Norwood VA Medical Center

Jump to: Lab Personnel, Education & Post-doctoral Training  Honors & Awards Editorship GrantsResearch Interests

Contact Us

Zheng Dong Lab

R&E Building, CB1124

706-721-2825

zdong@augusta.edu

706-721-6120

Lab Personnel:

Zheng Dong Lab

 

 

 

Qingqing Wei, PhD, Associate Professor
Man J. Livingston, MD/PhD, Research Scientist
Shixuan Wang, MD/PhD, Assistant Research Scientist
Zhengwei Ma, MD/PhD, Senior Research Associate
Jialing Yuan, Senior Research Associate
Azeeza Byers, Biomedical PhD Student
Yan Wu, MD, Visiting Researcher
Huangmin Li, MD Visiting Researcher
Qi Zhang, MD, Visiting Researcher

 

 

 

 

Education

1985-1989 B.Sc.

Microbiology, Fudan University, Shanghai, P.R. China

1989-1994 PhD

Physiology, Shanghai Institute of Physiology, Chinese Academy of Sciences

Post-doctoral Training

1994-1998

University of Texas Health Science Center (UTHSC) at San Antonio

Honors & Awards

2000 Lyndon B. Johnson Research Award American Heart Association
2001 Carl W. Gottschalk Scholar Award American Society of Nephrology
2001 Patricia W. Robinson Young Investigator National Kidney Foundation
2004 Career Development Award VISN 7, Department of Veterans Affairs
2005 Distinguished Faculty Award (Basic Science) Medical College of Georgia, MCG
2005 Distinguished Research Award School of Graduate Studies, MCG
2008 Research Career Scientist Award Department of Veterans Affairs
2011 Regents’ Professorship University System of Georgia
2013 Senior Research Career Scientist Department of Veterans Affairs
2016 Leon H. Charbonnier Endowed Chair 鶹AV
2017 Distinguished Faculty Award in Basic Science 鶹AV
2020 Senior Research Career Scientist Award Department of Veterans Affairs
2024 Distinguished Scientist Award Chinese American Society of Nephrology
2026 鶹AV Research Institute Distinguished Researcher of the Year 鶹AV

Journal Editorship

  • American Journal of Physiology-Renal Physiology (Associate Editor 2020-2026)
  • Kidney Diseases (Associate Editor 2019-present)
  • Journal of American Society of Nephology (Guest Associate Editor 2014, 2016, 2017, 2021)
  • Seminar in Nephrology (Guest Editor 2014)

 

Editorial Board Member
  • Kidney International (2010-present)
  • Journal of American Society of Nephrology (2015-present)
  • American Journal of Physiology-Renal Physiology (2011-2020)
  • American Journal of Physiology-Cell Physiology (2018-present)
  • and others
Book Editor

1) Essentials of Apoptosis: A Guide for Basic and Clinical ResearchEssentials of Apoptosis
Editors: Xiao-Ming Yin and Zheng Dong
1st edition, Humana Press, 259 pages.
ISBN: 978-1-59259-361-3, 2003

2nd edition, Humana Press, 707 pages.
ISBN: 978-1-60327-380-0, 2009


2) Cell Death in Biology and Diseases
Series Editor: Xiao-Ming Yin and Zheng Dong

Grant Reviewer
NIH
Regular/Chartered Member:
PBKD Study Section 2012-2016
Ad hoc reviewer:
PCD Study Section
2004.2
CSD Study Section
2006.2
PBKD Study Section 2006.10
PBKD Study Section 2007.6
PBKD Study Section 2008.2
PBKD Study Section 2010.10
PBKD Study Section 2011.2
PBKD Study Section 2011.6
Special panel ZRG1 DKUS-G 02, 2009.2
Special panel ZRG1 DKUS-A 58 2009.7
Special panel ZRG1 DKUS-K11 2009.8
Special panel ZRG1 DKUS-G 03, 2009.9
Special panel ZRG1 DKUS-G11, 2010.3
Special panel ZRG1 DKUS-A 05, 2011.8
Special panel ZRG1 OBT-Z 50, 2013.3
Special panel ZDK1 GRB-N z(J6), 2013.9
Botanical Dietary Supplement Research Centers (P50), 2014.10
NCI Special panel ZCA1 RPRB-M (M5) 2016.4
NCI Special panel ZCA1 SRB-1 (J1) R 2016.11
Special panel ZRG1 DKUS-J (03) 2016.12
Special panel ZRG1 DKUS-P (91) S 2017.01
Special panel ZRG1 DKUS-P (02) M 2017.04
Special panel ZRG1 IDM-C 50 2017.07
Special panel ZRG1 DKUS-P (04) 2017.10
NCI Special panel ZCA1 SRB-A (M1) S 2018.02
Special panel ZRG1 DKUS-L (55) 2018.06
Special panel ZRG1 DKUS-G (03) 2020.03
Special panel ZRG1 DKUS-P (03) 2020.07
NIDDK Chronic Renal Insufficiency Cohort (CRIC) Program 2021.5
Special panel ZRG1 DKUS-W (05) M 2021.12
Special panel ZDK1 GRB-S (J1) 1 2023.08
Special Panel ZDK1 GRB-6 (O1) 2024.7
Special Panel ZDK1 GRB-M (M1) 2025.04

Grant Reviewer Continued

VA:
Regular/Chartered Member:
Merit Review Panel for Nephrology 2010-2012
Ad hoc reviewer:
Career Development Award Program 2006.8
Merit Review Panel for Nephrology 2019.6
RCS/Promotions Review Committee 2019.5
Merit Review Panel for Nephrology 2019.12
Merit Review Panel for Nephrology 2020.11
RCS Review Committee  2021.5
Merit Review Panel for Nephrology 2021.11
ShEEP Review Panel 2023.01
Merit Review Panel for Nephrology 2023.11
Merit Review Panel for Nephrology 2024.05
ShEEP-MERP Review Panel 2024.08
Merit Review Panel for Nephrology 2025.5
ASN:
Regular/Chartered Member:
ASN Grants Review Committee 2022 - 2023
DoD:
Ad hoc reviewer: 
Army Life Science Grant Program 2004.6
EPSCoR IDeA Program 2006.7
PRCRP 2011 D-Kidney Cancer panel 2011.11
Army Medical Research and Material Command (MRMC) 2018.3
Others:
Ad hoc reviewer:
American Diabetes Association (ADA) fall cycle, 2008
Nebraska Research Initiative 2011.12, 2012.4
University of Toledo Intramural Program 2019.3; 2020.2
University of Texas Health Science Center at San Antonio 2019, 2020

University of Utah‐Washington University DRC Collaborative Pilot and Feasibility Program, 2017

University of Pennsylvania NIDDK Chronic Renal Insufficiency Cohort (CRIC) Program, 2021

University of Alabama NIDDK O’Brien Kidney Resource Alliance (OKRA) Program, 2026

International Grant Agencies

Canada:
Natural Sciences and Engineering Research Council of Canada (NSERC) 2020.11
China:
National Basic Research Program 2010.5
1000 Talents Program for Young Scholars 2012.11; 2014
Changjiang Scholar Program 2013.5; 2015.5; 2016.7; 2017.9
Outstanding Young Investigator Program 2012; 2015, 2016, 2018
Chinese National Science Foundation 2013-present
European Commission:
European Research Council 2023.12
France:
French National Research Agency 2015.4, 2016.4, 2020.3
Germany:
German Research Foundation 2013.5
Hong Kong:
Regular/Chartered Member:
Research Grant Council (RGC) of Hong Kong
Regular Chartered Member: 2020-2025

Ad hoc reviewer:
2013.3; 2014.3, 2015.3, 2015.8, 2016.3, 2016.9, 2017.3, 2018.3, 2019.3, 2026.4
Hungary:
Research Excellence Council of Hungary 2026.06
Israel:
US-Israel Binational Science Foundation 2022.1, 2024.3
Netherlands:
Dutch Cancer Society 2012.7
Dutch Kidney Foundation 2018.6
Netherlands Organization for Scientific Research 2021.6; 2022.11
Poland:
National Science Centre 2013.3, 2017.3
Romania:
Romanian National Council for Scientific Research 2011.11
Singapore:
Biomedical Research Council Program 2004.2, 2007.5, 2009.5
Switzerland:
Swiss National Science Foundation 2016.5, 2021.5
UK:
Cancer Research UK 2011.2, 2018.6
Medical Research Council (MRC) 2011.10, 2021.8
Yorkshire Cancer Foundation 2013.8
Kidney Research UK 2013.1, 2014.1, 2021.9
MRC UK Research and Innovation (UKRI) 2022.6, 2023

Research Interests

Dr. Dong and his group investigate the molecular mechanisms of kidney injury and repair as a pathological basis of renal diseases. Their current work is focused on mitochondria, autophagy, epigenetic regulation, and metabolism in acute kidney injury and diabetic kidney disease. As of August 15, 2026, they published 396 full-length articles in regarded journals that have been cited more than 55,000 times with a Google Scholar H-index of 111, attesting their contributions to the research of kidney disease and, cell stress response in general.

Contributions to Science

1. Delineate the mitochondrial pathway of apoptosis in hypoxic/ischemic kidney injury, discovered the role of Bak in the regulation of mitochondrial dynamics, and demonstrated the pathogenic role of mitochondrial dynamics disruption in kidney disease. Dr. Dong and his laboratory showed that the mitochondrial pathway is centered on the regulation of outer membrane permeabilization by Bcl-2 family proteins, resulting in the release of apoptogenic factors, such as cytochrome c. Their recent work further demonstrated a striking change of mitochondrial dynamics during cell injury and stress in diseases. They discovered a novel role of Bak in mitochondrial fragmentation and damage under cell stress and disease conditions. They further unveiled Bif-1 as a key regulator of mitochondrial inner membrane dynamics. These studies have been published in >50 research articles and have been cited for >6000 times. They have also contributed authoritative reviews in this field (eg. Zhan M. et. al. Kidney Int 2013; Linkermann et al. JASN 2014; Tang et al. Nature Rev Nephrol 2020). Representative original publications:

Representative Original Publications:

a. Brooks C, Wei Q, Feng L, Dong G, Tao Y, Mei L, Xie Z, Dong Z. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with Mitofusins. Proceedings of National Academy of Sciences (USA) 104: 11649-11654, 2007. PMCID: PMC1913853 (Highlighted by Faculty 1000; with news report) 104: 11649-11654, 2007. PMCID: PMC1913853 (Highlighted by Faculty 1000; with news report).

b. Brooks C, Wei Q, Cho S, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. Journal of Clinical Investigation 119: 1275-85, 2009. PMCID: PMC2673870 (with news report).

c. Wei Q, Dong G, Chen J, Ramesh G, Dong Z. Role of Bax and Bak in ischemic acute kidney injury shown by global and proximal tubule-specific knockout mouse models. Kidney International 84:138-48, 2013. PMCID: PMC3686831.  

d. Cho S, Xiao X, Wang , Gao H, Rafikov R, Black S, Huang S, Ding HF, Yoon Y, Kirken RA, Yin XM, Wang H-G, Dong Z. Bif-1 interacts with prohibitin-2 to regulate mitochondrial inner membrane during cell stress and apoptosis. Journal of American Society of Nephrology 30:1174-1191, 2019. PMCID: PMC6622411 (Highlighted on Journal cover).

2. Unveil a rapid DNA damage response during cisplatin-induced nephrotoxicity and have further determined its pathogenic role. These findings have been verified by other investigators, leading to the recognition of the DNA damage response mediated by ATR/Chk2/p53 as an important pathogenic mechanism in cisplatin nephrotoxicity. The studies have been published in >40 research articles and have been cited for ~3000 times. We have also contributed authoritative reviews in this field (eg. Pabla N et al. Kidney Int 2008; Jiang M et al. JPET 2008; Yang Y et al. Arch Toxicol 2014; Zhu S et al. Arch Toxicol 2015; Tang C et al. Pharmacology & Therapeutics 2019; Tang et al. Nature Rev Nephrol 2023).

Representative Original Publications:

a. Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. Journal of Biological Chemistry 286:10411-8. 2011. (Highlighted by Faculty 1000)

b. Pabla N, Bhatt K, Dong Z. Chk1-S is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proceedings of National Academy of Sciences (USA) 109: 197-202, 2012. (news report) c. Zhang D, Liu Y, Wei Q, Huo Y, Liu K, Liu F, Dong Z. Tubular p53 regulates multiple genes to mediate acute kidney injury Journal of American Society of Nephrology 25 (10):2278-89, 2014 (Highlighted on journal cover)

d. Fu Y, Xiang Y, Han Y, Cai J, Duan S, Chen A, Dong Z. DUSP26 protects against acute kidney injury by dephosphorylating p53 at serine 312. Nature Communications 17, 3208, 2026.

3. Demonstrate the first evidence of autophagy in acute kidney injury and further establish its role in kidney injury and repair. This line of work has been verified and extended by other investigators to show the role and regulation of autophagy in other renal diseases, suggesting a therapeutic approach for kidney protection. The studies have been published in >40 research articles and have been cited for ~4000 times. Dr. Dong and his laboratory have also contributed authoritative reviews in this field (Periyasamy-Thandavan Set. al. AJP-Renal 2009; Huber et al. Autophagy 2012; Livingston et al. Seminar in Nephrol 2014; Tang et al. Nature Rev Nephrol. 2020).

Representative Original Publications:

a. Periyasamy-Thandavan S, Jiang M, Wei Q, Smith R, Yin X, Dong Z. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney International 74, 631–640, 2008. PMID: 18509315. (Highlighted by Editorial: Kidney Int 74, 555-7).

b. Jiang M, Wei Q, Dong G, Komatsu M, Su Y, Dong Z. Autophagy in proximal tubules protects against acute kidney injury. Kidney International 82: 1271-1283, 2012. (highlighted by Editorial: Kidney Int 82: 1250-3; also by Nature Rev Nephrol).

c. Livingston M, Ding H, Huang S, Hill J, Yin X, Dong Z. Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction. Autophagy 12:976-98, 2016.

d. Livingston Mang J, Ganley I, Yin X, Dong Z. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. Autophagy 15(12):2142-2162, 2019

 

4. Report microRNA and DNA methylation as epigenetic mechanisms in ischemic and cisplatin nephrotoxic kidney injury. Dr. Dong and his laboratory have subsequently delineated the regulation of several specific microRNAs in kidney injury, protection, and repair. These studies, published in >30 research articles, have gained new insights into the pathogenesis of acute kidney injury and recovery, and have suggested novel therapeutic strategies by targeting epigenetics. They have also contributed several reviews (Bhatt et al. AJP-Renal 2011; Wei Q et al. IUBMB Life 2013; Kidney Int 2015; Guo C et al. Nature Rev Nephrol 2019).

Representative Original Publications:

a. Wei Q, Bhatt K, He H, Mi Q, Haase VH, Dong Z. Targeted deletion of Dicer from proximal tubules protects against ischemic acute kidney injury.  Journal of American Society of Nephrology 21: 756-761, 2010. PMCID: PMC2865746. (Highlighted on journal cover).

b. Guo C, Pei L, Xiao X, Wei Q, Chen JK, Ding HF, Huang S, Fan G, Shi H, Dong Z. DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8. Kidney International  92(5):1194-1205, 2017.

c. Wei Q, Sun H, Liu Y, Liu P, M.J. Livingston, Wang J, Liang M, Huo Y, Nahman S, Mei C, Dong Z. miR-668 is induced via HIF-1 in ischemic acute kidney injury to repress MTP18 for mitochondrial dynamics and cell survival. Journal of Clinical Investigation 128: 5448-5464, 2018 (Highlighted by Editorial: JCI 128:5216-8; with news report).

d. Ma Z,Li L,Livingston MJ,Zhang D,Mi Q, Zhang M, Ding HF, Huo Y, Mei C, Dong Z. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. Journal of Clinical Investigation 130(9):5011-5026, 2020 (news report).

5. Discover an alternative splice form of check-point kinase 1 that regulates cell cycle and DNA damage checkpoints, delineate the differential PKCδ signaling pathways in malignant and normal tissues, discover the novel interaction between Intu and STAT1 in the regulation of cell death and cilia in kidney injury, and reported the first evidence of stress granules in kidney disease.

Representative Original Publications:

a. Pabla N, Bhatt K, Dong Z. Chk1-S is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proceedings of National Academy of Sciences (USA) 109: 197-202, 2012. (news report)

b. Pabla N, Dong G, Jiang M, Huang S, Kumar MV, Messing R, Dong Z. PKCd is a novel regulator of cisplatin nephrotoxicity and effective target for renoprotection during cancer therapy. Journal of Clinical Investigation 121: 2709-2722, 2011. (news report)

c. Wang S, Liu A, Wu G, Ding H, Huang S, Dong Z. The CPLANE protein Intu protects kidneys from ischemia-reperfusion injury by targeting STAT1 for degradation. Nature Communications 2018 Mar 26; 9(1):1234. (Highlighted by Commentary: Nat Rev Nephrol. 2018;14:354) d. Wang S, Kwon SH, Su Y, Dong Z. Stress granules are formed in renal proximal tubular cells during metabolic stress and ischemic injury for cell survival. Am J Physiol Renal Physiol. 2019;317:F116-F123.

 

mitochondria

Confocal image of mitochondria. In control cells, mitochondria are elongated and filamentous. After injury, mitochondria are fragmented into short rods or spheres. The morphological change contributes to mitochondrial damage and apoptosis (Brooks…Dong. PNAS 104: 11649-11654, 2007.  Journal of Clinical Investigation 119:1275-85, 2009).

 

Dong MiceOvarian cancer xenografts were established in nude mice, which were then treated with cisplatin with or without Rottlerin, a PKCδ inhibitor. In this and other tumor models, Rottlerin and relevant protect protect kidneys and enhance cancer therapy effect during cisplatin treatment. (Pabla…Dong.  Journal of Clinical Investigation 121: 2709-2722, 20112011).

Slide 1 miR-668

miR-668 is induced via HIF-1 in ischemic acute kidney injury to repress MTP18 for mitochondrial dynamics and cell survival. Wei…Dong.  Journal of Clinical Investigation 128: 5448-5464, 2018

Axis impairs renal tubular autophagy in Diabetic Kidney Disease JCI

p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. Ma…Dong. Journal of Clinical Investigation 130(9):5011-5026, 2020

Approaches:

Gene cloning, transfection, expression, knockout (antisense and RNAi), promoter assay, genotyping, Northern/Southern blot, microRNA analysis, immunoblotting, immunoprecipitation, immunofluorescence, immunohistochemistry and light/fluorescence/confocal microscopy. In vitro and in vivo experimental models, germline and tissue specific gene knockout mice.

Grant Support:

National Institutes of Health; Department of Veterans Affairs

 

Representative Publications (2023-2026):

A. Original Studies

1. * Livingston MJ, Shu S, Fan Y, Li Z, Jiao Q, Yin XM, Venkatachalam MA, Dong Z. Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis. Autophagy. 2023 Jan;19(1):256-277.

2. * Zhu J, Xiang X, Hu X, Li C, Song Z, Dong Z. miR-147 Represses NDUFA4, Inducing Mitochondrial Dysfunction and Tubular Damage in Cold Storage Kidney Transplantation. J Am Soc Nephrol. 2023 Aug 1;34(8):1381-1397.

3. * Wen L, Wei Q, Livingston M, Dong G, Li S, Hu X, Li Y, Huo Y, Dong Z. PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4. Translation Research. 2023 Mar;253:31-40.

4. * Wang S, Liu A, Su Y, Dong Z. Deficiency of the Planar Cell Polarity Protein Intu Delays Kidney Repair and Suppresses Renal Fibrosis after Acute Kidney Injury. Am J Pathol. 2023; 193(3):275-285

5. * Hu X, Ma Z, Li S, Wen L, Huo Y, Wu G, Manicassamy S, Dong Z. Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity. Laboratory Investigation 2023 March; 103(3):100009

6. * Li S, Livingston MJ, Ma Z, Hu X, Wen L, Ding HF, Zhou D, Dong Z. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight. 2023 Mar 14:e166643.

7. * Livingston MJ, Zhang M, Kwon SH, Chen JK, Li H, Manicassamy S, Dong Z. Autophagy activates EGR1 via MAPK/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair. Autophagy. 2024 May;20(5):1032-1053

8. * Xiao X, Wang W, Guo C, Wu J, Zhang S, Shi H, Kwon S, Chen J, Dong Z. Hypermethylation leads to the loss of HOXA5, resulting in JAG1 expression and NOTCH signaling contributing to kidney fibrosis. Kidney International 2024 Jul;106(1):98-114.

9. * Fu Y, Xiang Y, Zha J, Chen G, Dong Z. Enhanced STAT3/PIK3R1/mTOR Signaling Triggers Tubular Cell Inflammation and Apoptosis in Septic-Induced Acute Kidney Injury: Implications for Therapeutic Intervention. Clinical Science (Lond). 2024 Mar 20;138(6):351-369.

10. * Liu J, Livingston MJ, Dong G, Wei Q, Zhang M, Mei S, Zhu J, Zhang C, Dong Z. HIF-1 contributes to autophagy activation via BNIP3 to facilitate renal fibrosis in hypoxia in vitro and UUO in vivo. Am J Physiol Cell Physiol. 2024, 326: C935–C947.

11. * Zhu J, Xiang X, Shi L, Song Z, Dong Z. Identification of Differentially Expressed Genes in Cold Storage-associated Kidney Transplantation. Transplantation. 2024, 108(10):2057-2071.

12. * Shu S, Wang H, Cai J, Chen A, Dong Z. Establishment and characterization of a mouse model for studying kidney repair in diabetes. Am J Physiol Renal Physiol. 2024 Nov 1;327(5):F758-F774.

13. * Wei Q, Huang J, Livingston MJ, Wang S, Dong G, Xu H, Zhou J, Dong Z. Pseudogene GSTM3P1 derived long non-coding RNA promotes ischemic acute kidney injury by target directed microRNA degradation of kidney-protective mir-668. Kidney International. 2024 Oct;106(4):640-657.

14. * Wei Q, Xiao X, Huo E, Guo C, Zhou X, Hu X, Dong C, Shi H, Dong Z. Hypermethylation and downregulation of microRNA-219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis. Molecular Therapy 2025 Jan 8;33(1):249-262.

15. * Wu W, Fu Y, Li H, Xiang Y, Zeng Y, Cai J, Dong Z. GALNT3 in Ischemia-Reperfusion Injury of the Kidney. J Am Soc Nephrol. 2025 Mar 1;36(3):348-360.

16. * Wang Y, Zeng Y, Fu Y, Liu Z, Hu X, Tang C, Cai J, Dong Z. Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair. Kidney Int. 2025 May;107(5):869-887.

17. * Cai J, Wei J, Zeng Y, Yi M, Zhou Y, Ai K, Chen W, Liu Y, Chen G, Chen A, Sun L, Liu H, Duan S, Cheng J, Wang CY, Dong Z. UBC9-associated SUMOylation contributes to beta-catenin activation and kidney fibrosis. Kidney Int. 2025 Oct;108(4):642-657.

18. * Huang J, Dong Z, Wei Q. Pseudogene-derived long non-coding RNAs GSM3P1/Gstm2-ps1 exacerbate sepsis-associated acute kidney injury by suppressing their parent gene translation. Am J Pathol. 2026 196(5):1098-1115.

19. * Xiang Y, Fu Y, Liu Z, Han Y, Wu W, Cai J, Zhang D, Dong Z. Down-Regulation of TFEB With Defective Autophagy in the Susceptibility of Aging Kidneys to Septic Acute Kidney Injury. Aging Cell. 2026 Aug;25(8):e70644.

20. * Liu Z, Fu Y, Wu W, Cai J, Dong Z. Mir452 protects against septic acute kidney injury by targeting Apaf1 to relieve CASP9-mediated suppression of autophagy. Autophagy. 2026 Jul 13:1-19.

21. * Fu Y, Xiang Y, Han Y, Cai J, Duan S, Chen A, Dong Z. DUSP26 protects against

acute kidney injury by dephosphorylating p53 at serine 312. Nature Communications 2026 Feb 26;17(1):3208.

22. * Cai J, Pan J, Zeng Y, Wei J, Yi M, Xiang Y, Liu Z, Duan S, Wang C, Dong Z. SUMOylation protects against sepsis-associated acute kidney injury by stabilizing IκBα. Molecular Therapy 2026 Feb 4;34(2):1277-1291.

23. * Ma Z, Hu X, Manicassamy K, Dong Z. KLF5 is upregulated via NF-kB to promote maladaptive kidney repair and CKD progression. J Am Soc Nephrol (online)

B. Invited Reviews/ Commentaries

24. * Tang C, Livingston JM, Safirstein R, Dong Z. Cisplatin nephrotoxicity: new insights and therapeutic implications. Nature Reviews Nephrology. 2023 Jan;19(1):53-72.

25. * Xiang Y, Fu Y, Wu W, Tang C, Dong Z. Autophagy in acute kidney injury and maladaptive kidney repair. Burns Trauma. 2023 Jan 22;11:tkac059.

26. * Wen J, Zeng M, Yang Y, Liang Y, Fu P, Dong Z. Exosomes in Diabetic Kidney Disease. Kidney Dis (Basel). 2023 Feb 14;9(3):131-142.

27. * Chen G, Dong Z. Targeting a Single Codon to Rescue Septic Acute Kidney Injury. Journal of American Society of Nephrology. 2023 Feb 1;34(2):179-181.

28. * Wang S, Hu J, Dong Z. From Primary Cilia and Planar Cell Polarity to Kidney Injury and Repair. Nephron. 2023 Jul 17:1.

29. * Cai J, Dong Z. Two-way communication between the nucleus and mitochondria via a micropeptide in renal fibrosis. Kidney Int. 2023 May;103(5):833-835.

30. * Liu Z, Dong Z.Beta 2 adrenergic receptor agonists: a new treatment for diabetic kidney disease? American Journal of Physiology-Renal Physiology. 2024 Jan 1;326:F1-F2.

31. * Fu Y, Xiang Y, Wei Q, Ilatovskaya D, Dong Z. Rodent models of AKI and AKI-CKD transition: an update in 2024. American Journal of Physiology-Renal Physiology. 2024 Apr 1;326(4):F563-F583

32. * Liu Z, Fu Y, Yan M, Zhang S, Cai J, Chen G, Dong Z. microRNAs in kidney diseases: Regulation, therapeutics, and biomarker potential. Pharmacology & Therapeutics. 2024 Oct;262:108709. doi: 10.1016/j.pharmthera.2024.108709.

33. Cai J, Dong Z. C-reactive protein in diabetic kidney disease: A new therapeutic avenue? Molecular Therapy. 2025 Jan 8;33(1):26-27

34. Xia M, Li Y, Liu Y, Dong Z, Liu H. Single-Cell RNA-Sequencing Analysis Provides Insights into IgA Nephropathy. Biomolecules. 2025 Jan 29;15(2):191.

35. * Fu Y, Dong Z. When ACE2 Turns Against the Kidney: A Paradox Unveiled in Heme-Induced AKI. Am J Physiol Renal Physiol. 2025; 328(6):F828-F829.

36. * Wei S, Fu Y, Zeng Y, Wu W, Cai J, Dong Z.Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential. Pharmacol Ther. 2025 Nov;275:108930. doi: 10.1016/j.pharmthera.2025.108930. Epub 2025 Sep 25.

37. * Liu Z, Fu Y, Cai J, Chen G, Dong Z. Non-Coding RNAs as Targets of Acute Kidney Injury Therapy: Ready for Primetime? Kidney360. 7(7):p 1677-1688, July 2026

38. * Fu Y, Dong Z. S1P-sPRR axis in renal ischemia-reperfusion injury: inflammation via a cut. Clin Sci (Lond). 2026 Apr 15;140(4):533-536.

39. * Xue C, Wei Q, Wang S, Byers A, Huang J, Chen JK, Dong Z. Brain-Derived Neurotrophic Factor and Associated Signaling in Kidney Diseases. FASEB J. 2026 Jul 15;40(13):e72113.

40. * Fu Y, Livingston M, Juan Cai, Dong Z The Many Ways of Selective Autophagy in Kidney Health and Disease. Nature Reviews Nephrology 2026 Aug;22(8):559-574.

 

Great Doctors, Great Medicine Since 1828. 

University Shield

鶹AV

1120 15th Street, 鶹AV, GA 30912

  •   Campus Maps
  •   Campus Contacts
  • A-Z Directory
  • Degrees & Programs
  • Employment
  • Accessibility
  • Accreditation
  • Campus Safety
  • Compliance Hotline
  • Privacy Notices
  • Title IX / Sexual Misconduct
Apply Now Give Now

© 2026 鶹AV